Apoptosis Inhibitor Expressed by Macrophages Tempers Autoimmune Colitis and the Risk of Colitis-Based Carcinogenesis in TCRα−/− Mice Ikuko HarutaNoriyuki ShibataKeiko Shiratori OriginalPaper 06 July 2007 Pages: 549 - 556
Correction of Th1-dominant Cytokine Profiles by High-dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura Chengshan GuoXiaoxia ChuMing Hou OriginalPaper 06 July 2007 Pages: 557 - 562
Polymorphisms of Genes for Programmed Cell Death 1 Ligands in Patients with Rheumatoid Arthritis Shu-Chen WangChia-Hui LinJeng-Hsien Yen OriginalPaper 28 June 2007 Pages: 563 - 567
Carboxypeptidase D: A Novel TGF-β Target Gene Dysregulated in Patients with Lupus Erythematosus Norman-Philipp HoffDaniel DegrandiJens Ulrich Wurthner OriginalPaper 20 July 2007 Pages: 568 - 579
The Effect of Blockade of Tumor Necrosis Factor α on VLA-1+T-Cells in Rheumatoid Arthritis Patients Ilan BankShomron Ben-HorinHanan Gur OriginalPaper 22 September 2007 Pages: 580 - 588
Enhanced In Vivo Protein Synthesis in Circulating Immune Cells of ICU Patients Anna JanuszkiewiczMaria KlaudeJan Wernerman OriginalPaper 06 July 2007 Pages: 589 - 597
Migration of Tumor Antigen-Pulsed Dendritic Cells After Mucosal Administration in the Human Upper Respiratory Tract Shigetoshi HoriguchiTomokazu MatsuokaYuriko Tanaka OriginalPaper 28 June 2007 Pages: 598 - 604
Relationship Between Eosinophilia and Levels of Chemokines (CCL5 and CCL11) and IL-5 in Bronchoalveolar Lavage Fluid of Patients With Mustard Gas-Induced Pulmonary Fibrosis Ali EmadYasaman Emad OriginalPaper 10 July 2007 Pages: 605 - 612
Differential Contribution of the CysLTR1 Gene in Patients with Aspirin Hypersensitivity Seung-Hyun KimEun-Mi YangHae-Sim Park OriginalPaper 20 July 2007 Pages: 613 - 619
Development of a Maturing T-Cell-Mediated Immune Response in Patients with Idiopathic Parkinson’s Disease Receiving r-metHuGDNF Via Continuous Intraputaminal Infusion Suzanna M. TatarewiczXin WeiMichael S. Moxness OriginalPaper 14 July 2007 Pages: 620 - 627
A Multicenter, Prospective, Open Label, Historically Controlled Clinical Trial to Evaluate Efficacy and Safety in Primary Immunodeficiency Diseases (PID) Patients of Flebogamma® 5% DIF, the Next Generation of Flebogamma® Melvin BergerThe Flebogamma® 5% DIF Investigators OriginalPaper 02 October 2007 Pages: 628 - 633
The Phenomenon of Spontaneous Genetic Reversions in the Wiskott-Aldrich Syndrome: A Report of the Workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4–7, 2006 Donn M. StewartFabio CandottiDavid L. Nelson BriefCommunication 10 August 2007 Pages: 634 - 639
Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes Anna ŠediváC. I. Edvard SmithHans D. Ochs OriginalPaper 12 September 2007 Pages: 640 - 646
Resetting the Adaptive Immune System After Autologous Stem Cell Transplantation: Lessons from Responses to Vaccines D. M. C. BrinkmanC. M. Jol-van der ZijdeM. J. D. van Tol OriginalPaper Open access 10 August 2007 Pages: 647 - 658
The Effect of Natural Killer Cell Killer Ig-Like Receptor Alloreactivity on the Outcome of Bone Marrow Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID) M. D. KellerD. F. ChenR. H. Buckley Erratum 22 September 2007 Pages: 659 - 659